Newsfeeds Archive - Spark Newswire

2 minute read

Aldeyra Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying

April 4, 6:23 AM

The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

ALDX

2 minute read

Positive News For Skin Health: Aldeyra Therapeutics’ ADX-629 Achieves Key Milestones in Atopic Dermatitis Study

By Vandana Singh

December 19, 2:56 PM

Aldeyra Therapeutics Inc (NASDAQ: ALDX) released topline results from a Phase 2 clinical trial of ADX-629, an investigational RASP modulator, in

ALDX

1 minute read

Aldeyra Therapeutics Schedules Conference Call And Webcast On Tuesday, December 19, 2023, At 8:00 a.m. To Announce Top-Line Results From Phase 2 Clinical Trial Of ADX-629 In Patients With Atopic Dermatitis

By Benzinga Newsdesk

December 18, 5:03 PM

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra) today announced it will host a webcast and conference call on Tuesday, December 19, 2023, at 8:00 a.m. (ET) to provide top-line results from a Phase 2 clinical trial of

ALDX

1 minute read

FDA Rejects Aldeyra Therapeutics’ Dry Eye Disease Candidate, Asks For Additional Study

By Vandana Singh

November 28, 12:10 PM

The FDA issued a complete response letter to Aldeyra Therapeutics Inc's (NASDAQ: ALDX) New Drug Application (NDA) of reproxalap, an investigational drug

ALDX

4 minute read

Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

November 1, 1:59 PM

Gainers

AIZ

3 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

November 1, 1:31 PM

Gainers Cellectis (NASDAQ:CLLS) shares moved upwards by 188.6% to $2.8 during Wednesday’s regular session. Trading volume for this…

ALDX

1 minute read

What’s Going On With Aldeyra Therapeutics Stock?

By Erica Kollmann

November 1, 11:52 AM

Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shares are trading higher Wednesday after the company announced that it entered into an exclusive opti

ALDX

2 minute read

Reported Earlier, Aldeyra Therapeutics Enters Into Exclusive Option Agreement With AbbVie For License To Develop And Commercialize Reproxalap

By Benzinga Newsdesk

November 1, 10:51 AM

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that it has entered into

ABBV